Refractory bullous pemphigoid with prurigo nodularis successfully treated with dupilumab monotherapy
Saved in:
Main Authors: | Po-Ta Lai (Author), Han-Chi Tseng (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases
by: Liang J, et al.
Published: (2024) -
Bullous pemphigoid successfully treated with dupilumab
by: Daniela de Abreu e Silva Martinez, et al.
Published: (2024) -
Bullous pemphigoid developed after dramatic improvement of severe prurigo nodularis
by: Tomoko Hiraiwa, et al.
Published: (2023) -
Recalcitrant prurigo nodularis after COVID‐19 vaccination and successfully treated by dupilumab
by: Shang‐shang Wang, et al.
Published: (2023) -
Methotrexate for refractory prurigo nodularis
by: Mariam Al Zaabi, et al.
Published: (2017)